CCK-B receptor-positive small cell lung cancers, breast tumors, and ovarian tumors, representIng the molecular basis of a possible autocrine
نویسنده
چکیده
Cholecystokinin (CCK)-A and CCK.B/gastrln receptors were evalu ated with in vitro receptor autoradlography in 406 human tumors of various origins using a sulfated lasI@labelod CCK decapeptide analogue lasI.([email protected], Me@1).CCK 26-33 and *asI.Inbelod Leu15-gastrin as radioligands. CCK-B/gastrln receptors were found frequently in medul lat@r thyroid carcinomas (92%), In small cell lung cancers (57%), in astrocytomas (65%), and in stromal ovarian cancers (100%). They were found occasionally In gastroenteropancreatic tumors, breast, endometrial, and ovarian adenocarcinomas. They were either not expressed or rarely expressed In colorectal cancers, differentiated thyroid cancers, non-small cell lung cancers, meninglomas, neuroblastomas, schwannomas, glioblas tomas, lymphomas, renal cell cancers, prostate carcinomas, and the re maining neuroendocrine tumors (Le., pituitary adenomas, pheochromo cytomas, paragangilomas, and parathyroid adenomas). CCK-A receptors were expressed rarely In tumors except In gastroenteropancreatic tumors (38%), meningiomas (30%), and some neuroblastomas (19%). The iden tified CCK-A and CCK-B receptors were specific and of high affinity In the subnanomolar range. The rank order of potency of various CCK analogues was: sulfated CCK-8 L-364,718 )D nonsulfated CCK-8 L. 365,260 gastrIn for CCK-A receptors and sulfated CCK-8 > gas trin nonsulfated CCK-8 > L-365,260 > L-364,718 for CCK-B recep tors. CCK-B receptors could also be selectively and specifically labeled with a newly designed nonsulfated lasI.(D.Tyr@Gly, Nle@')-CCK 26-33. Gastrin mRNA measured by in sins hybrkllzation was present In most CCK-B receptor-positive small cell lung cancers, breast tumors, and ovarian tumors, representIng the molecular basis of a possible autocrine growth regulation of these tumors. Gastrin and CCK mRNAs were lack mg In medullary thyroid cancers. Thus, these results may have patho genie, diagnostic, differential diagnostic, and therapeutic implications.
منابع مشابه
Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Cholecystokinin (CCK)-A and CCK-B/gastrin receptors were evaluated with in vitro receptor autoradiography in 406 human tumors of various origins using a sulfated 125I-labeled CCK decapeptide analogue 125I-(D-Tyr-Gly, Nle28,3l)-CCK 26-33 and 125I-labeled Leu15-gastrin as radioligands. CCK-B/gastrin receptors were found frequently in medullary thyroid carcinomas (92%), in small cell lung cancers ...
متن کاملImaging features of estrogen-negative breast cancers: a correlation study with human epidermal growth factor type II overexpression
Background: Estrogen-negative breast cancers have different clinical course, prognostic features and treatment response in comparison to estrogen receptor-positive (ER-positive) breast cancers. Human epidermal growth factor receptor 2 (HER2) oncoprotein has found to have a pivotal role in natural cell growth and cell division and is suggested to be directly related to tumor invasiveness in brea...
متن کاملPreparation and evaluation of 67Ga-DOTA-Bombesin (7-14) as a tumor scintigraphic agent
Introduction: Bombesin is a 14-aminoacid peptide isolated from frog skin. The mammalian counterparts of the frog peptide are neuromedin B (NMB) and gastrin-releasing peptide (GRP). Bombesin (BBN) is a peptide showing high affinity for the gastrin releasing peptide receptor (GRPr). Prostate, small cell lung cancer, breast, gastric, and colon cancers are known to over...
متن کاملEvaluation of Nucleostemin Gene Expression as a New Molecular Marker in Breast Tumors
Background & Aims: Nucleostemin is one of the stem cell enriched proteins which encodes a novel nucleolar GTP-binding protein found at high levels in the adult and embryonic stem (ES) cells but not in terminally differentiated cells. It is also expressed in tumor cell lines as well as in the several types of human cancers. Due to the increasing rate of breast cancer in recent years, in the pres...
متن کاملCCK2 receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours
The wild-type cholecystokinin type 2 (CCK(2)) receptor is expressed in many gastrointestinal and lung tumours. A splice variant of the CCK(2) receptor with retention of intron 4 (CCK(2)Ri4sv) showing constitutive activity associated with increased tumour growth was described in few colorectal, pancreatic and gastric cancers. Given the potential functional and clinical importance of this spliceo...
متن کامل